No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs553504201 |
chr9:136820184-136820185 |
Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs118073576 |
chr9:136820216-136820217 |
Enhancers Weak transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs576323036 |
chr9:136820372-136820373 |
Enhancers Weak transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs535724335 |
chr9:136820432-136820433 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs373771237 |
chr9:136820434-136820435 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs111467193 |
chr9:136820445-136820446 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs182925390 |
chr9:136820460-136820461 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs572813436 |
chr9:136820516-136820517 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs369024369 |
chr9:136820524-136820525 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs62576939 |
chr9:136820594-136820595 |
Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
11 |
rs2428005 |
chr9:136820604-136820605 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs200697948 |
chr9:136820695-136820696 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs187896209 |
chr9:136820784-136820785 |
Weak transcription Enhancers Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs410383 |
chr9:136820814-136820815 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs543514367 |
chr9:136820874-136820875 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs561684673 |
chr9:136820876-136820877 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs386372 |
chr9:136820880-136820881 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs370314478 |
chr9:136820932-136820933 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs138885451 |
chr9:136820975-136820976 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs374463772 |
chr9:136820989-136820990 |
Enhancers Weak transcription Active TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs192394160 |
chr9:136821007-136821008 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs541286674 |
chr9:136821013-136821014 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs559205615 |
chr9:136821037-136821038 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs573553320 |
chr9:136821044-136821045 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs112134070 |
chr9:136821069-136821070 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs694505 |
chr9:136821074-136821075 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs694511 |
chr9:136821085-136821086 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs531668093 |
chr9:136821092-136821093 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs79762258 |
chr9:136821100-136821101 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs187591468 |
chr9:136821114-136821115 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs142698975 |
chr9:136821144-136821145 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs10993875 |
chr9:136821151-136821152 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs554101631 |
chr9:136821170-136821171 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs566350359 |
chr9:136821173-136821174 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs192972024 |
chr9:136821178-136821179 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs56259406 |
chr9:136821183-136821184 |
Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs528906665 |
chr9:136821215-136821216 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs372676736 |
chr9:136821281-136821282 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs10993876 |
chr9:136821314-136821315 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs555430544 |
chr9:136821326-136821327 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs573687609 |
chr9:136821366-136821367 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs541197087 |
chr9:136821377-136821378 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs559142376 |
chr9:136821378-136821379 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs2073884 |
chr9:136821379-136821380 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs184690786 |
chr9:136821399-136821400 |
Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs564090145 |
chr9:136821408-136821409 |
Flanking Active TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs78429413 |
chr9:136821413-136821414 |
Flanking Active TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs11790353 |
chr9:136821485-136821486 |
Flanking Active TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs11790354 |
chr9:136821503-136821504 |
Flanking Active TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs549944227 |
chr9:136821505-136821506 |
Flanking Active TSS Enhancers Weak transcription Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|